Flecainide is a class IC anti-arrhythmic agent recommended for maintenance of sinus
rhythm in patients with atrial fibrillation and/or supraventricular tachycardia who
don't have structural heart disease. Flecainide is well known to be pro-arrhythmic
as well. Polypharmacy is defined as taking four or more drugs by a patient. Polypharmacy
is common in eledryl population with an estimated prevalence of 40%. Polypharmacy
poses a significant hazard due to significant durg-drug interactions.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the American Medical Directors AssociationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
